medline.ch Onkologie

	Residential radon exposure and lung cancer histology and stage: a population-based ecological study in Central Germany. J Cancer Res Clin Oncol Ernst P, Rachow T, Henn S, Hammersen JF, Dittrich S, Heßmer A, Hillig A, Heßmer A, Hochhaus A. PMID: 42218725 [PubMed - as supplied by publisher]
	Impact of control selection strategies on GWAS results: a study of prostate cancer in the UK biobank. Brief Bioinform Lu J, Thygesen JH, Beaumont RN, Weedon MN, Green HD. PMID: 42218711 [PubMed - in process]
	Exosomal lncRNAs as molecular switches driving macrophage-tumor co-evolution in breast cancer. Clin Exp Med Javadian M, Zeinali T, Rajabi M, Mehrasa Z, Boogari M, Ramezani F, Samaeinasab S, Mahmoudi Z, Hakimi H, Sabzehban R, Najafi K, Esmaeili K, Khaksarhaghani Z, Tahmasebi S, Rezaei R. PMID: 42218707 [PubMed - as supplied by publisher]
	Small interfering RNA (siRNA)-based targeting breast cancer therapy. Discov Oncol Talebi A, Khorrami A, Oruji F, Shabani S, Hajazimian S, Nasiri H, Khansalar S, Isazadeh A, Akbari M. PMID: 42218706 [PubMed - as supplied by publisher]
	Visualizing eligibility gaps between muscle-invasive bladder cancer trials and real-world patients. Jpn J Clin Oncol Ichiyama T, Narita T, Sekine Y, Shinohara M, Kawashima Y, Kobayashi M, Numakura K, Mikami J, Fujita N, Okamoto T, Yamamoto H, Narita S, Sato S, Habuchi T, Ohyama C, Hatakeyama S. PMID: 42218684 [PubMed - as supplied by publisher]
	Ten years of translational innovation in HER2-targeted immune cell therapy - A comprehensive review of the work of the University of Debrecen Cell and Molecular Therapy Research Group. Magy Onkol Vereb G, Szö. PMID: 42218679 [PubMed - indexed for MEDLINE]
	Premedication with steroids in breast cancer - supportive treatment or tumour growth promotion? Magy Onkol Butz H, Oláh A, Patócs A. PMID: 42218678 [PubMed - indexed for MEDLINE]
	Contextâ€‘dependent targeting of thioredoxin reductase 1 in cancer: a mechanistic review. Magy Onkol Biri-Kovács B, Úri K, Andor A, Mohanraj M, Kolonics A, Pató ZA, Arnér ESJ. PMID: 42218677 [PubMed - indexed for MEDLINE]
	Reframing cancer drug resistance: transporters, persister cells, senescence, and emerging therapeutic strategies. Magy Onkol Nagy P, Kis AK, Bajtai E, Haffaressas IL, Gombos B, Bereczki D, Szebényi K, Szakács G, Tóth S, Füredi A. PMID: 42218676 [PubMed - indexed for MEDLINE]
	3D bioprinted in vitro models in cancer metabolism research. Magy Onkol Gábriel Z, Szalai F, Varga V, Olsen HW, Förhécz N, Csikós B, Pet, Krencz I, Moldvai D, Sebestyén A. PMID: 42218675 [PubMed - indexed for MEDLINE]
	Impact of Dedicated Care Coordination on Access to Multidimensional Support Services in Young-Onset Colorectal Cancer: A Pragmatic Trial. JCO Oncol Pract Moon J, Maghanoy E, Higbie VS, Smith GL, Harrison D, White MG, Guraieb-Trueba M, Behman R, Smith PM, Messick CA, Bednarski BK, Konishi T, Rodriguez-Bigas MA, Chang GJ, Smith JJ, You YN. PMID: 42218659 [PubMed - as supplied by publisher]
	Neoadjuvant Sacituzumab Govitecan in Patients With Muscle-Invasive Bladder Cancer: Primary Results of the SURE-01 Trial. J Clin Oncol Necchi A, de Jong JJ, Maiorano BA, Proudfoot JA, Basile G, Cigliola A, Mercinelli C, Tateo V, Piacentini M, Crupi E, Pastorino GL, Latini G, Tomasi E, Davicioni E, Moschini M, Brembilla G, Colecchia M, de Cobelli F, Ross JS, Madison R, Tambaoan CFB, Briganti A, Montorsi F. PMID: 42218654 [PubMed - as supplied by publisher]
	Structured exercise program following adjuvant chemotherapy for colon cancer: A cost-utility analysis of the CHALLENGE trial. J Clin Oncol Chan KK, Chu RW, Cheung MC, Courneya KS, O'Callaghan CJ, Vardy JL, Gill S, Friedenreich C, Wong RK, Dhillon HM, Coyle V, Chua NS, Jonker DJ, Meyer RM, Ahmed S, Zalcberg JR, Clarke SJ, O'Brien P, Tang PA, Wong R, Lim HJ, Burge ME, Brundage M, Hay AE, Tu D, Booth CM. PMID: 42218651 [PubMed - as supplied by publisher]
	From Tumour to Bloodstream: Advancing PD-L1 Testing With Liquid Biopsies in Non-Small Cell Lung Cancer. Cytopathology Leporati R, Callegari V, Ancora A, Palmieri M, Riccò B, Cabitza E, Trudu L, Di Emidio K, Chiavelli C, Eccher A, Mastrolia I, Catani V, Bettelli S, Guaitoli G, Dominici M, Bertolini F. PMID: 42218596 [PubMed - as supplied by publisher]
	Modeling distress in cancer patients using a fuzzy logic approach based on expert consensus. World J Surg Oncol Pandey A, Thomas BC, Pandey M. PMID: 42218534 [PubMed - as supplied by publisher]
	A logNII-based model for predicting pathological complete response following neoadjuvant therapy in esophageal squamous cell carcinoma: a retrospective single-center study. World J Surg Oncol Zhang M, Huang J, Wang C, Yang B, Lu T. PMID: 42218485 [PubMed - as supplied by publisher]
	Cytoreductive radical prostatectomy in patients with high-volume metastatic prostate cancer achieving deep biochemical response to contemporary systemic therapy: a multicentre, prospective cohort study. BMC Med Huang C, Guo H, Gao W, Huang M, Ji G, Rui R, He S, Yu Y, Zhang N, Tian Y, Niu Y, Li X, Zhou L. PMID: 42218463 [PubMed - as supplied by publisher]
	Development and external validation of multiple machine learning-based models for breast cancer-specific survival prediction in postoperative patients with invasive breast cancer: a study based on the SEER database and an external cohort. BMC Cancer Liu S, Liu J, Li D, Mo Q. PMID: 42218459 [PubMed - as supplied by publisher]
	Rewiring the immune circuit: programming tumor-draining lymph node immunity with nanotechnology. J Nanobiotechnology Chen X, Zou M, Li N, Zhou Z, Xu R, Feng W, Guo Z, Zhao X, Cui L. PMID: 42218454 [PubMed - as supplied by publisher]
	Extracellular vesicle and particle biomarkers in cancer: a machine learning blueprint for liquid biopsy. J Nanobiotechnology Yu J, Xu G, Li Y, Huang M, Yang L, Peng X. PMID: 42218435 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 1939843

Seite 1 von 96993

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung